Signup/Login
If you want to receive notifications of upcoming IPOs, you need to simply sign up or sign in with social networks.
Signup/Login
Can you determine which companies are good and which ones - the trash?
Free Pro-version
IPO Filter
Monitor
IPO today
Upcoming IPO
Informatica Inc. (INFA)
Arteris, Inc. (AIP)
Rent The Runway, Inc. (RENT)
Informatica Inc. (NYSE)
Fluence Energy, Inc. (FLNC)
Ensemble Health Partners, Inc. (ENSB)
Lianbio (LIAN)
Candela Medical, Inc. (CDLA)
Globalfoundries, Inc. (GFS)
Solo Brands, Inc. (DTC)
Udemy, Inc. (UDMY)
Hireright Holdings Corporation (HRT)
Airsculpt Technologies, Inc. (AIRS)
Priced IPO
Aris Water Solutions, Inc. (ARIS)
Minerva Surgical, Inc (UTRS)
Xilio Therapeutics, Inc. (XLO)
Enfusion, Inc. (ENFN)
Portillos Inc. (PTLO)
The Vita Coco Company, Inc. (COCO)
P10, Inc. (PX)
Ventyx Biosciences, Inc. (VTYX)
Runway Growth Finance Corp (RWAY)
Context Therapeutics (CNTX)
Stronghold Digital Mining, Inc. (SDIG)
Cyngn (CYN)
Mink Therapeutics, Inc. (INKT)
Paragon 28, Inc. (FNA)
Ihs Holding Limited (IHS)
Gitlab Inc. (GTLB)
Lucid Diagnostics, Inc. (LUCD)
Healthcare Triangle (HCTI)
AvidXchange (AVDX)
Cognition Therapeutics, Inc. (CGTX)
More companies

Monterey Bio Acquisition (MTRYU)

Sector - SPAC

Price chart

-100%
Return from IPO

Last SPACs News

IPO Profile

About company

They are a blank check company. They will seek to identify, through the experience and expertise of their management team and board of directors, a biotech company that has demonstrated success and is primed to thrive in the rapidly evolving biotech industry. Their acquisition strategy is to leverage their expertise and network relationships to identify, negotiate and acquire one or more business targets (i.e. companies), and/or in-license one or more assets, or combine business targets with in-licensed assets with the ultimate objective of building a public clinical stage biotech enterprise. It is their goal to evaluate business targets that are developing or enabling development of pre-commercial therapeutic candidates across a broad array of therapeutic areas, with an initial focus on oncology and immunology. They have built their management team around the concept of combining individuals with extensive experience, varied backgrounds and skill sets. Their Chief Executive Officer, Sanjeev Satyal, has a proven and successful track record in the biotech industry and has robust operational experience. William McKeever, Chief Financial Officer, also brings a robust skill set that will complement those of their Chief Executive Officer. Mr. McKeever has more than twenty years of significant experience in the healthcare industry and has successfully held key positions in equity research, portfolio management and investment banking. As a result, Mr. McKeever, has broad experience in identifying attractive companies.
Industry
Blank Checks
CEO CFO
-
Employees Founded
0 2020

Contacts

Address: 17 State Street 21st Floor New York, Ny 10004

Telephone: (917) 267-0216

Web page:

IPO information

First Trade Date 10/1/2021
Status Priced
Exchange NASDAQ
Lockup Period Expiration .Pro
Quiet Period Expiration .Pro
Old Price Range
-
Share prices ($)

Shares & Volumes

Shares Initial (MM) 10
Shares Revised (MM) 10
Expected offer amount (MM) $100
Realized offer amount(MM) $100

Financial Data (last reporting year)

Market Cap (MM) $125.0
Revenues (MM) $0
Net Income (Loss) (MM) $0

Voting

What do you think will happen with the MTRYU share price after the next 3-6 months? 🔥 (+ 10% or more, flat (+ -10%), -10% or less)

Number of votes: img
Underwriters
Chardan
CO-Managers
-